'Luckily, I don't believe in statistics': survey of women's understanding of chance of success with futile fertility treatments.

Advanced maternal age Cumulative live birth rate Decision making In vitro fertilization Maternal age Unrealistic optimism

Journal

Reproductive biomedicine online
ISSN: 1472-6491
Titre abrégé: Reprod Biomed Online
Pays: Netherlands
ID NLM: 101122473

Informations de publication

Date de publication:
Feb 2021
Historique:
received: 26 02 2020
revised: 27 09 2020
accepted: 28 09 2020
pubmed: 1 12 2020
medline: 27 11 2021
entrez: 30 11 2020
Statut: ppublish

Résumé

Why are women who face poor prognoses for success in assisted reproductive technology (ART) treatment choosing to pursue procedures using their own eggs, despite receiving information that their chances of success are very low. Cross-sectional study based on an anonymous questionnaire distributed to women aged between 43 and 45 years, undergoing ART using their own oocytes, at six public outpatient fertility clinics and three public in-hospital IVF units in Israel between 2015 and 2016. The main outcome measure was personal estimation of chance to achieve a live birth after the current ART treatment cycle and the cumulative estimated rate after all the treatment cycles the patient intended to undergo. Response rate was 70.0%, with 91 participants of mean age 43.8 ± 0.7 years. Participants estimated their delivery rates after the next ART treatment cycle at 49.0 ± 31.8% (response rate 93.4%) and their cumulative delivery rates after all the ART treatments they would undergo at 57.7 ± 36.3% (response rate 90.1%). This is significantly higher than the predicted success rates of 5% and 15%, respectively (both P < 0.001), which are based on national register data. Nearly one-half of patients rated themselves as having a better than average chance of conception (47.3%). Women do not pursue futile treatments because they lack information. Despite being informed of the low success rates of conception using ART treatments, many patients of advanced maternal age have unrealistically high expectations from ART, essentially ignoring their estimated prognosis when deciding on treatment continuation. Future work should examine the psychological reasons behind continuing futile fertility treatments.

Identifiants

pubmed: 33250411
pii: S1472-6483(20)30531-9
doi: 10.1016/j.rbmo.2020.09.026
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

463-470

Informations de copyright

Copyright © 2020 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.

Auteurs

Talya Miron-Shatz (T)

Ono Academic College, Center for Medical Decision Making, Tzahal St 104, Kiryat Ono, Israel; Winton Centre for Risk and Evidence Communication, Wilberforce Road, Cambridge CB3 0WA, UK.

Hananel Holzer (H)

Department of Obstetrics and Gynecology, Hadassah Medical Center Ein Kerem POB 12000 Jerusalem, Israel.

Ariel Revel (A)

Reproductive Medicine and In Vitro fertilization Unit, Department of Obstetrics and Gynecology, Yitzhak Shamir Medical Center (formerly Assaf Harofeh Medical Center), affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel, Zerifin, Israel.

Ariel Weissman (A)

IVF Unit- Department of Obstetrics and Gynecology, Edith Wolfson Medical Center, Ha-Lokhamim St 62, Holon, 5822012, Sackler Faculty of Medicine, Tel Aviv University, Israel.

Danit Tarashandegan (D)

Ono Academic College, Center for Medical Decision Making, Tzahal St 104, Kiryat Ono, Israel.

Arye Hurwitz (A)

Department of Obstetrics and Gynecology, Hadassah Medical Center Ein Kerem POB 12000 Jerusalem, Israel.

Michael Gal (M)

Faculty of Medicine, Hebrew University of Jerusalem, IVF unit, Department of Obstetrics and Gynecology, Shaare Zedek Medical Center, Shmu'el Bait St 12 Jerusalem 9103102, Israel.

Avraham Ben-Chetrit (A)

Faculty of Medicine, Hebrew University of Jerusalem, IVF unit, Department of Obstetrics and Gynecology, Shaare Zedek Medical Center, Shmu'el Bait St 12 Jerusalem 9103102, Israel.

Amir Weintraub (A)

Faculty of Medicine, Hebrew University of Jerusalem, IVF unit, Department of Obstetrics and Gynecology, Shaare Zedek Medical Center, Shmu'el Bait St 12 Jerusalem 9103102, Israel.

Amir Ravhon (A)

IVF Unit- Department of Obstetrics and Gynecology, Edith Wolfson Medical Center, Ha-Lokhamim St 62, Holon, 5822012, Sackler Faculty of Medicine, Tel Aviv University, Israel.

Avi Tsafrir (A)

Faculty of Medicine, Hebrew University of Jerusalem, IVF unit, Department of Obstetrics and Gynecology, Shaare Zedek Medical Center, Shmu'el Bait St 12 Jerusalem 9103102, Israel. Electronic address: avits@netvision.net.il.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH